High prevalence of somatic PIK3CA and TP53 pathogenic variants in the normal mammary gland tissue of sporadic breast cancer patients revealed by duplex sequencing

被引:13
|
作者
Kostecka, Anna [1 ,2 ]
Nowikiewicz, Tomasz [3 ,4 ]
Olszewski, Pawel [2 ]
Koczkowska, Magdalena [1 ,2 ]
Horbacz, Monika [2 ]
Heinzl, Monika [5 ]
Andreou, Maria [2 ]
Salazar, Renato [5 ]
Mair, Theresa [5 ]
Madanecki, Piotr [1 ]
Gucwa, Magdalena [1 ]
Davies, Hanna [6 ]
Skokowski, Jaroslaw [7 ]
Buckley, Patrick G. [8 ]
Peksa, Rafal [9 ]
Srutek, Ewa [3 ]
Szylberg, Lukasz [10 ,11 ]
Hartman, Johan [12 ,13 ,14 ]
Jankowski, Michal [3 ]
Zegarski, Wojciech [3 ]
Tiemann-Boege, Irene [5 ]
Dumanski, Jan P. [2 ,6 ]
Piotrowski, Arkadiusz [1 ,2 ]
机构
[1] Med Univ Gdansk, Fac Pharm, Gdansk, Poland
[2] Med Univ Gdansk, 3P Med Lab, Gdansk, Poland
[3] Ludwik Rydygiers Coll Med UMK, Dept Surg Oncol, Bydgoszcz, Poland
[4] Prof F Lukaszczyk Oncol Ctr, Dept Breast Canc & Reconstruct Surg, Bydgoszcz, Poland
[5] Johannes Kepler Univ Linz, Inst Biophys, Linz, Austria
[6] Uppsala Univ, Dept Immunol Genet & Pathol & Sci Life Lab, Uppsala, Sweden
[7] Med Univ Gdansk, Dept Surg Oncol, Gdansk, Poland
[8] Genu Sci Genom Ctr, Dublin, Ireland
[9] Med Univ Gdansk, Dept Patomorphol, Gdansk, Poland
[10] Prof F Lukaszczyk Oncol Ctr, Dept Tumor Pathol, Bydgoszcz, Poland
[11] Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Dept Perinatol Gynaecol & Gynaecol Oncol, Bydgoszcz, Poland
[12] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
[13] Karolinska Univ Hosp, Dept Pathol, Stockholm, Sweden
[14] Karolinska Univ Hosp, MedTech Labs, Bioclinicum, Stockholm, Sweden
关键词
GENE-EXPRESSION PATTERNS; HIGH-RISK; MUTATIONS; LANDSCAPE; NUMBER; WOMEN;
D O I
10.1038/s41523-022-00443-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The mammary gland undergoes hormonally stimulated cycles of proliferation, lactation, and involution. We hypothesized that these factors increase the mutational burden in glandular tissue and may explain high cancer incidence rate in the general population, and recurrent disease. Hence, we investigated the DNA sequence variants in the normal mammary gland, tumor, and peripheral blood from 52 reportedly sporadic breast cancer patients. Targeted resequencing of 542 cancer-associated genes revealed subclonal somatic pathogenic variants of: PIK3CA, TP53, AKT1, MAP3K1, CDH1, R81, NCOR1, MED12, CBFB, T8X3, and TSHR in the normal mammary gland at considerable allelic frequencies (9 x 10(-2) - 5.2 x 10(-1)), indicating clonal expansion. Further evaluation of the frequently damaged PIK3CA and TP53 genes by ultra-sensitive duplex sequencing demonstrated a diversified picture of multiple low-level subclonal (in 10(-2)-10(-4) alleles) hotspot pathogenic variants. Our results raise a question about the oncogenic potential in non-tumorous mammary gland tissue of breast-conserving surgery patients.
引用
收藏
页数:10
相关论文
共 16 条
  • [1] Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
    Li, Guoli
    Guo, Xinwu
    Chen, Ming
    Tang, Lili
    Jiang, Hui
    Day, Julia X.
    Xie, Yueliang
    Peng, Limin
    Xu, Xunxun
    Li, Jinliang
    Wang, Shouman
    Xiao, Zhi
    Dai, Lizhong
    Wang, Jun
    PLOS ONE, 2018, 13 (09):
  • [2] Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer
    Chang, Pi-Yueh
    Chen, Jinn-Shiun
    Chang, Shih-Cheng
    Wang, Mei-Chia
    Chang, Nai-Chung
    Wen, Ying-Hao
    Tsai, Wen-Sy
    Liu, Wei-Hsiu
    Liu, Hsiu-Ling
    Lu, Jang-Jih
    ONCOTARGET, 2017, 8 (42) : 72352 - 72362
  • [3] Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors
    Thulin, Anna
    Andersson, Carola
    Ronnerman, Elisabeth Werner
    De Lara, Shahin
    Chamalidou, Chaido
    Schoenfeld, Arnd
    Kovacs, Aniko
    Fagman, Henrik
    Enlund, Fredrik
    Linderholm, Barbro K.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [4] Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing
    Nakauchi, Chiaki
    Kagara, Naofumi
    Shimazu, Kenzo
    Shimomura, Atsushi
    Naoi, Yasuto
    Shimoda, Masafumi
    Kim, Seung Jin
    Noguchi, Shinzaburo
    CLINICAL BREAST CANCER, 2016, 16 (05) : 418 - 423
  • [5] PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients
    Li, A-Jian
    Li, Hua-Guang
    Tang, Er-Jiang
    Wu, Wei
    Chen, Ying
    Jiang, Hui-Hong
    Lin, Mou-Bin
    Yin, Lu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (05) : 631 - 640
  • [6] Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes
    Kim, Ji-Yeon
    Lee, Eunjin
    Park, Kyunghee
    Park, Woong-Yang
    Jung, Hae Hyun
    Ahn, Jin Seok
    Im, Young-Hyuck
    Park, Yeon Hee
    ONCOTARGET, 2017, 8 (17) : 27997 - 28007
  • [7] Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study
    Jauhri, Mayank
    Bhatnagar, Akanksha
    Gupta, Satish
    Bp, Manasa
    Minhas, Sachin
    Shokeen, Yogender
    Aggarwal, Shyam
    TUMOR BIOLOGY, 2017, 39 (02)
  • [8] Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer
    Chen, Xinyi
    Guo, Yonghai
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xu, Ye
    Xie, Yuntao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (05) : 1235 - 1242
  • [9] BRCA1, BRCA2, TP53, PIK3CA, PTEN and AKT1 genes mutations in Burkina Faso breast cancer patients: prevalence, spectrum and novel variant
    Ouedraogo, Serge Yannick
    Zoure, Abdou Azaque
    Zeye, Moutanou Modeste Judes
    Kiendrebeogo, Touwendpoulimde Isabelle
    Zhou, Xi
    Sawadogo, Alexis Yobi
    Simpore, Jacques
    Chen, Hanchun
    MOLECULAR GENETICS AND GENOMICS, 2022, 297 (05) : 1257 - 1268
  • [10] Association between the Prevalence of Somatic Mutations in PIK3CA Gene in Tumors and Clinical and Morphological Characteristics of Breast Cancer Patients
    M. L. Filipenko
    N. A. Os’kina
    I. A. Oskorbin
    O. V. Mishukova
    L. K. Ovchinnikova
    E. S. Gershtein
    N. E. Kushlinskii
    Bulletin of Experimental Biology and Medicine, 2017, 163 : 250 - 254